CTOs on the Move

Sonoma Biotherapeutics

www.sonomabio.com

 
Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient`s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma`s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.sonomabio.com
  • 201 Haskins Way Suite 203
    South San Francisco, CA USA 94080
  • Phone: 415.992.6245

Executives

Name Title Contact Details
Heidi Hagen
Chief Technical Officer Profile

Funding

Sonoma Biotherapeutics raised $40M on 02/06/2020
Sonoma Biotherapeutics raised $30M on 09/30/2020

Similar Companies

OncoResponse

OncoResponse Inc., a privately held immuno-oncology company, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to the discovery of cancer therapeutics.

Alphora Research Inc

Alphora Research Inc is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stemline Therapeutics

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.

Elusys Therapeutics

Elusys Therapeutics is a Pine Brook, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pronutria

Amino acid biology is fundamental to life, regulating biological pathways critical to health. A variety of conditions occur when amino acid pathways become dysregulated.